Systematic review with meta‐analysis: diagnostic overlap of microscopic colitis and functional bowel disorders
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Summary: Background: Microscopic colitis shares certain common clinical manifestations with functional bowel disorders, especially diarrhoea‐dominant irritable bowel syndrome (IBS) and functional diarrhoea. However, the exact relationship between microscopic colitis and functional bowel disorders has not been systematically assessed. Aim: To conduct a systematic review and meta‐analysis on the diagnostic overlap between functional bowel disorders and microscopic colitis. Methods: We searched MEDLINE, EMBASE and SCOPUS databases, as well as the abstract books of the major gastroenterology meetings, to investigate the prevalence of microscopic colitis among patients with functional bowel disorders (considering all subtypes of both disorders) and vice versa. Data were pooled with a random‐effects model. Results: Of 227 references identified, data were collected from 26 studies and a total of 5,099 adult patients. The pooled prevalence any type of functional bowel disorders in patients who present diagnostic criteria of microscopic colitis was 39.1% (95% CI: 22.8–56.6%; I2: 97%) and was higher for lymphocytic colitis than for collagenous colitis (40.7% vs. 28.4%, respectively; P = 0.58). The prevalence of microscopic colitis in functional bowel disorders patients was 7% (95% CI: 3.6–11.4%), reaching 9.8% (95% CI: 4.4–17.1%; I2: 95%) in patients exhibiting diarrhoea‐dominant IBS, nonsignificantly higher than microscopic colitis rates among patients with constipation‐dominant IBS (1.3%) or mixed‐dominant IBS (1.9%). Conclusions: There is a significant overlap of symptoms between microscopic colitis and functional bowel disorders, especially in diarrhoeal subtypes. The high proportion of microscopic colitis among diarrhoea‐dominant functional syndromes should serve as a call for more active diagnosis in selected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
The functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267 · cited 1×
“Publication bias was evaluated with the aid of a funnel plot, the asymmetry of which was assessed with Begg Mazumda’s rank test(27) along with the Egger(28) and Harbord tests.(29) For the primary outcomes, planned subgroup analyses were performed based on the primary disease studied (MC or FBDs) and their subtypes (ly…”
MethodGlobal Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Munn, Z., Moola, S., Riitano, D., & Lisy, K. (2014) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2014.71 · Cited by 1,479
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Dunlop, S. P., Jenkins, D., & Spiller, R. C. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07542.x · Cited by 359 · cited 1×
“of MC after finding an increase in the colonic serotoninpositive cell density, which probably results from the interaction between lymphocytes and enterochromaffin cells.(70) Serotonin is known to accelerate intestinal motil-”
BackgroundCremon, C., Gargano, L., Morselli-Labate, A. M., Santini, D., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Corinaldesi, R., & Barbara, G. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.94 · Cited by 342
The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach
Drossman, D. A., & Thompson, W. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-1009 · Cited by 309
Mearin, X. B. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520152584770 · Cited by 240
Chey, W. D., Nojkov, B., Rubenstein, J. H., Dobhan, R. R., Greenson, J. K., & Cash, B. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.55 · Cited by 175 · cited 1×
“In contrast, several other studies have shown conflicting results, with either lower or higher prevalence of organic disease in IBS patients.(41) A previ-”
ResultSpiegel, B. M. R., Gralnek, I. M., Bolus, R., Chang, L., Dulai, G. S., Naliboff, B., & Mayer, E. A. (2005) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.016 · Cited by 87
Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
Plavšić, I., Hauser, G., Tkalčić, M., Pletikosić, S., & Salkić, N. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/490183 · Cited by 37 · cited 1×
“IBS, and, in the absence of a colonoscopy with colonic mucosal biopsies, there is no marker for an accurate differential diagnosis between the two conditions.(14) Currently, diagnosis of IBS is symptom-based, with diagnostic criteria for each IBS-subtype as well as for functional diarrhoea.”
Background
Cited by
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
Arasaradnam, R. P., Brown, S., Forbes, A., Fox, M. R., Hungin, P., Kelman, L., Major, G., O’Connor, M., Sanders, D. S., Sinha, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315909 · Cited by 332
“140 141 The American Gastroenterology Association has developed guidelines on the medical management of microscopic colitis.”
BackgroundInfluentialRome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome
Barbara, G., Grover, M., Bercik, P., Corsetti, M., Ghoshal, U. C., Ohman, L., & Rajilić-Stojanović, M. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.07.011 · Cited by 281
Savarino, E., Zingone, F., Barberio, B., Marasco, G., Akyuz, F., Akpinar, H., Barboi, O., Bodini, G., Bor, S., Chiarioni, G., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12259 · Cited by 146
Metadata
- Authors
- Guagnozzi, D., Arias, Á., & Lucendo, A. J.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2016-02-24
- Volume
- 43
- Issue
- 8
- Pages
- 851-862
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2285795028
- Cited by
- 69
- References
- 15
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.